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Abstract 
Apathy is a symptom of many neurodegenerative and neuropsychiatric disorders, such as 
Huntington's disease and schizophrenia. Apathy is often conceptualized as a combination of 
three domains, cognitive, behavioral, and emotional, characterized by impaired goal-directed 
behavior. The striatum has been shown to be significantly associated with executive functions 
and planned motor behavior via projection to the prefrontal cortex (PFC). Due to its connection 
to the PFC and its involvement in the basal ganglia motor circuit, the striatum is thought to be a 
significant part of the circuit that controls goal-directed behavior. The purpose of this study was 
to investigate the relationship between apathy severity and dorsal striatal grey matter 
concentration across several disorders, specifically Huntington's disease and schizophrenia. With 
access to the PREDICT-HD and FBIRN datasets, structural MRI images and clinical 
assessments were collected from 823 and 178 participants, respectively. We employed the use of 
SBM to isolate relevant basal ganglia components and used the resulting loading coefficients for 
a multivariate analysis. In parallel, we also conducted a univariate analysis using segmented 
subcortical volumetric data. We then constructed a mixed linear model to examine the 
relationship between apathy and any gray matter patterns in the striatum. In Huntington’s 
disease, our results indicate that apathy is significantly related to the caudate and putamen 
atrophy with covarying in the medial PFC. In schizophrenia, our results indicate that apathy is 
significantly related to the putamen with covarying regions in the gyrus rectus and orbital medial 
PFC. We concluded that Huntington’s disease and schizophrenia manifest apathy in different 
ways in unique structures.  
 
 
APATHY IN SCHIZOPHRENIA AND HUNTINGTON’S DISEASE 3 
Apathy and Striatal Gray Matter Decay in Schizophrenia and Huntington’s Disease 
 Huntington’s disease (HD) is a progressive neurodegenerative disorder characterized by 
involuntary movement and cognitive impairments stemming from a genetic abnormality in the 
HTT gene (Ciarochi et al., 2016). Schizophrenia is a progressive disorder characterized by an 
array of psychotic, affective, and cognitive symptoms, including hallucinations, anhedonia, and 
attention deficits. Despite being different classes of disorders, HD and schizophrenia share a 
specific negative symptom in the form of apathy, which is often conceptualized as a lack of 
motivation to act and quantified as a pathology of goal-directed behavior. Furthermore, the 
striatum, consisting of areas such as the caudate, putamen, pallidum, and nucleus accumbens, is 
an area often associated with both disorders and is heavily implicated in the physiological 
mechanisms behind apathy. If it is the case that the physiological underpinnings of apathy reside 
in the dorsal striatum and this area is also a common target implicated in both disorders, then it 
stands to reason that comparing gray matter volume in the dorsal striatum and apathy scores of 
patients of both diseases might yield a similar pattern. 
 Even though apathy is a common symptom reported in both disorders, defining the 
construct of apathy has been a challenge for researchers. Currently, apathy is generally defined 
as a reduction in goal-directed behavior. However, goal-directed behavior requires a series of 
cognitive steps, including planning, initiation, and execution, which means that apathy represents 
a break down at any point during processing. There are three general types of apathy: emotional, 
cognitive, and auto-activation. The emotional domain of apathy refers to reduced ability to 
appropriately associate affective signals to behavior and external stimuli, which can lead to the 
misrepresentation of rewards and the inability to process behavioral consequences. The cognitive 
domain of apathy refers to deficits in the cognitive ability to plan the intended action; apathy, in 
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this case, could stem from issues with working memory and the generation of strategies. The 
auto-activation domain of apathy refers to difficulty in engaging the motor program necessary 
for the behavior or any thought process related to the intended behavior. Given these three 
conceptualizations of apathy, the one most related to the dorsal striatum is the cognitive domain, 
since it is highly related to executive function, which might implicate the striatal projections to 
the PFC. 
 The basal ganglia, more specifically the striatum, has been found to be heavily implicated 
in the development and execution of goal-directed behaviors, especially in aspects of motivation 
like reward prediction and learning, through its projections to the prefrontal cortex (PFC) (Levy 
& Dubois, 2006; Gradin et al., 2011). As a whole, the basal ganglia is thought to transform 
cortical signals into directed behavior and, as such, is implicated in motor learning, habits, and 
the selection of actions. Furthermore, it also thought that, through the co-activation of the direct 
and indirect pathway, the basal ganglia could promote and suppress specific motor programs 
based on cortical input (Cui et al., 2013). If this is the case, then lesions in the basal ganglia 
could definitely be a critical factor in the onset of apathy. The striatum has several key cortical 
inputs that have been found to be related to apathy. The dorsal striatum, more specifically the 
caudate, is connected to the lateral PFC; lesions to this circuit has been found to impair working 
memory, ability to generate strategies and other related abilities that represent the disruption of 
the cognitive process, which may lead to apathy. Other areas, such as the pallidum and nucleus 
accumbens, have also been implicated in the onset of apathy since they are involved in a 
functional circuit with the orbital-medial PFC, which seems likely to play an important role in 
the flow of affective information due to its limbic and sensory inputs (Levy & Dubois, 2006). 
The orbital-medial PFC projects to the caudate and ventral striatum; subsequent output from 
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these structures end up terminating at the pallidum and substantia nigra pars reticulata. This 
connection between orbital-medial PFC and striatum seems to play an essential role in the 
processing and allocation of emotional information. For these reasons, the present study will 
focus on the striatum, particularly the caudate, putamen, and globus pallidus. 
 Apathy is one of the most reported symptoms in HD with reported rates of 48% or higher 
depending on the sample and methodology (Rosenblatt & Leroi, 2000; Paulsen et al., 2001; van 
Dujin et al., 2010). Although the basal ganglia and PFC are heavily implicated in apathy in other 
disorders, the neural mechanisms are not very well understood in the context of HD (Levy & 
Dubois, 2006). However, recent HD studies looking at gray matter concentration in the basal 
ganglia have found that dorsal striatal gray matter concentration decreases across prodromal HD 
stages and that apathy is related to these gray matter patterns (Ciarochi et al., 2016; Misiura et 
al., 2019). Considering the literature on apathy, results implicating the caudate and putamen are 
not surprising, since they’ve been found to be significant in other neurodegenerative disorders 
(Carriere et al., 2014; Gradin et al., 2011; Bruen et al., 2008). Other areas that are usually 
implicated in apathy, such as the pallidum and nucleus accumbens, have yet to be discovered in 
the context of HD. 
Barch & Dowd (2010) suggest that individuals with schizophrenia suffer from apathy 
because they have a hard time using information from previous experiences to drive current and 
future behavior. The implication here is that other facets of goal-directed behavior, such as the 
hedonics and planning aspect, theoretically remain intact. Fronto-striatal circuits are thought to 
underlie relevant behaviors, such as reward prediction and some aspects of reinforcement 
learning. Evidence from fMRI studies using reward anticipation tasks specifically identify the 
dorsal striatum as a key structure in predicting rewards and differentially activating to prediction 
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errors (Knutson et al., 2000; Mucci et al., 2015). The dorsal striatum has also been implicated in 
learning deficits from reward feedback (Koch et al., 2010). In addition, the caudate and nucleus 
have been found to be differentially responsible for different aspects of reward expectancy. 
Haruno & Kawato (2006) found that the putamen was correlated with stimulus-reward 
association, while the caudate was correlated with reward prediction error. Furthermore, there 
are studies that use monetary incentive tasks on schizophrenic patients that find reduced 
activation exclusively in the putamen, caudate, or both (Knustson et al., 2000; Koch et al., 2010; 
Mucci et al., 2015). The ventral striatum is a well-known area in the field of reward due to its 
role in the dopaminergic mesolimbic pathway. Several fMRI studies confirm its involvement in 
the manifestation of apathy in schizophrenia patients, especially with positive prediction errors 
of reward (Berns et al., 2001; Kirschner et al., 2016; Simon et al., 2010). As a result, it stands to 
reason that a decrease in activation within the striatum could lead to an inability to process future 
rewards properly and, therefore, be unable to initiate the proper mechanisms that lead to 
behavior. Studies using structural imaging of schizophrenia patients have yet to identify the basal 
ganglia and have mostly identified gray matter decreases in frontal regions and the ACC 
(Bortolon et al., 2018). Theoretically, it is thought that apathy should be related to the fronto-
striatal circuits since there are known connections between these regions and they’ve been 
implicated in key processes related to apathy, such as emotional processing, executive planning, 
and motor function. This seems to be supported by the functional evidence that identifies both 
frontal and striatal regions in the same and different tasks.  
This study will examine the relationship between apathy and gray matter volume in the 
striatum across schizophrenia and HD. To do this, we will use structural T1 images and 
psychiatric measurements from the Neurobiological Predictors of Huntington's Disease 
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(PREDICT-HD) and the Function Biomedical Informatics Research Network Data Repository 
(FBIRN) datasets. Independent component analysis (ICA) will then be used to isolate 
components that maximally represent the specific structures within the striatum and, in 
combination with apathy measures from the corresponding scale in each dataset, a regression 
model will be built to examine the relationship between apathy and each of these components. In 
addition, we will also make separate regression models with subcortical volumetric data for the 
relevant structures. Since apathy is one of the most reported prodromal HD symptoms and 
correlates with increasing severity of HD symptoms, this study included participants in various 
prodromal stages of HD to maximize participants. The central hypothesis is that apathy will be 
highly related to decreased striatal, specifically caudate, putamen, and globus pallidus, gray 
matter, and this pattern will hold in schizophrenia and HD. 
Methods 
Participants 
 For HD, the data was extracted from the PREDICT-HD dataset, which includes data from 
32 different sites (Paulsen et al., 2008). This dataset includes over 1400 prodromal and healthy 
controls over the age of 18. In this data set, demographic information, such as sex and age, and 
HD specific symptomology information, such as motor, cognitive, and psychiatric scores, were 
included for the participants, although some participants are missing certain items. In this study, 
we used all participants who had neuroimaging data along with the following variables: apathy, 
depression, intracranial volume, and subcortical volume (n = 823) (Table 1). Out of these 
participants, 174 of them were healthy controls, which means even though their family history 
indicates a risk of HD, they lack the genetic mutation. For more information regarding data 
collection, please refer to Paulsen et al., (2014). 
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 For schizophrenia, the data was extracted from the FBIRN dataset, which includes data 
from 7 different sites (Keator et al., 2016). This dataset includes sMRI, fMRI, DTI, behavioral, 
and demographic data. It also included clinical assessments, such as the SANS, providing 
symptological information about schizophrenia patients. In this study, we used all participants 
that had neuroimaging data along with the following variables: apathy, depression, intracranial 
volume, and subcortical volume (n = 178) (Table 2). 
 
 
 
 
 
 
Table 1 
PREDICT-HD Demographics 
 
Characteristics 
prHD 
(n = 649) 
Mean (SD) 
Controls 
(n = 174) 
Mean (SD) 
Sex (M/F) 236/413 61/113 
Age 39.81 (10.61) 44.1 (11.93) 
Low/Medium/High 201/226/222 N/A 
Apathy 12.29 (5.42) 10.84 (4) 
Depression 52.7 (13.31) 48.8 (10.34) 
Note. Low/Medium/High group categories denote prHD disease stage, based on CAPd 
scores, as defined by Zhang et al., 2011. 
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Clinical Scores 
 For prHD, the apathy scores used for this study were from a modified 24-item form of the 
UHDRS apathy subscale, which asks questions about recent behavior (Grace, 2011). This apathy 
subscale score is calculated as a summation of eight apathy related items (Duff et al., 2010). We 
used companion-reported apathy scores for this analysis because previous research suggests that 
companion ratings are more consistently associated with disease progression. Depression scores 
for this study were taken from the Symptom Checklist 90 (SCL90) depression subscale. 
Companion reported scores were used to maintain consistency with apathy items. 
 For schizophrenia, the apathy scores used were from two measures of the SANS. The 
first measure we used was the global apathy score, which is a subjective rating of apathy as a 
whole without any specific restrictions, and the second measure consisted of averaging avolition 
and apathy measurements in an attempt to represent apathy better. Depression scores were 
sourced from the PANSS depression item.  
Preprocessing 
Table 2 
FBIRN Demographics 
 
Characteristics 
Schizophrenia 
(n = 178) 
Mean (SD) 
Sex (M/F) 133/45 
Age 39.06 (11.49) 
Apathy-Avolition 3.33 (2.22) 
Global Apathy 4.75 (3.27) 
Depression 2.21 (1.3) 
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 For PREDICT-HD, the segmentation methods of SPM5 were used to normalize images 
to Montreal Neurological Institute (MNI) space, reslice to 2×2×2 mm, and segment into gray, 
white, and CSF images (Ashburner & Friston, 2000). Data quality was checked by correlations 
against the segmented templates with a threshold of 0.9. When the subject’s segmented gray 
matter data did not meet or exceed the threshold, it was removed from consideration. Data were 
smoothed by a Gaussian filter of 10 mm Full Width Half Maximum (FWHM). See Ciarochi et 
al., (2016) for further details. 
 For FBIRN, we used T1-weighted structural MRI images that were normalized to the 
standard MNI template using a 12-parameter affine model, resliced to a voxel size of 
2 × 2 × 2 mm, and segmented into GM, white matter, and CSF using SPM12. Data were 
smoothed by a Gaussian filter of 10 mm Full Width Half Maximum (FWHM). See Menningen et 
al., (2019) for further details. 
Brain Volumes 
 For PREDICT-HD, we used subcortical volumes extracted from high-resolution T1 
images using the BRAINSTools algorithm (Ghayoor, Vaidya, & Johnson, 2013; Kim, Magnotta, 
Liu, & Johnson, 2014). For FBIRN, volumes were extracted using FreeSurfer 5.1 (van Erp et al., 
2016). The subcortical volumes that were used in this study included the caudate, putamen, and 
thalamus. The caudate and putamen are areas of interest that have been found to be related to 
apathy, while the thalamus was used as a control (Aylward, Nopolous, et al., 2011). For the 
models using these volumes, we calculated them as a percentage of ICV. 
Source-Based Morphometry 
 Using the GIFT toolbox in MATLAB, source-based morphometry was used to extract 
components, via ICA, from preprocessed (segmented, normalized, unmodulated, and smoothed) 
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gray matter images. The number of components was determined to be 23 for the PREDICT-HD 
dataset and 25 for the FBIRN dataset by a minimum description length (MDL) criterion. Using 
the infomax algorithm, the resulting one-dimensional matrix for each component was divided 
into a mixing matrix, which expresses the relationship between the subjects and components, and 
source matrix, which expresses the relationship between the components and brain voxels. For 
the mixing matrix, each row indicates how each component contributes to a single subject, while 
each column indicates the contribution of one component to all subjects. Conversely, each row of 
the source matrix indicates how one component contributes to different brain voxels, while the 
columns indicate how one voxel contributes to each component. As a result, this yields a loading 
coefficient and a spatial map for each component. To ensure the reliability of these components, 
the ICASSO software package was used to confirm the stability of each component (20 iterations 
and minimum stability of 0.90).  
 After obtaining the resulting spatial maps for the components, we manually selected 
components that contained significant gray matter variation in the striatum, specifically the 
caudate, putamen, pallidum, and nucleus accumbens. This was done by analyzing the spatial 
maps using xjview with a threshold of z ≥ 3 and looking for gray matter variation in the 
component. First, we isolated the global maximum to see the area that experiences the most 
variation. If the global maximum was not in the striatum, we located the striatum and observed to 
see if there was any significant variation. If there was no variation in the striatum, then we 
moved on to the next component. Ultimately, we found three components of this nature in the 
HD (Figures 1-3) analysis and four components in the schizophrenia analysis (Figures 4-7). 
These components were included in subsequent models. 
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Figure 1 
PREDICT-HD Component #3 
Figure 2 
PREDICT-HD Component #5 
Note. These values represent negative z values. This component mainly represents the 
caudate. 
Note. These values represent negative z values. This component mainly represents 
the thalamus. 
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Figure 3 
PREDICT-HD Component #17 
Figure 4 
FBIRN Component #1 
Note. These values represent negative z values. This component mainly represents the putamen. 
Note. These values represent negative z values. This component mainly represents the 
caudate. 
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Figure 6 
FBIRN Component #15 
Figure 5 
FBIRN Component #11 
Note. These values represent positive z values. This component mainly represents the 
thalamus 
Note. These values represent negative z values. This component mainly represents the 
putamen 
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Regression Models 
 We constructed various mixed linear models with the lme4 package (Verbeke & 
Molenberghs, 2000) in R to account for the site as a random-effects factor. Sex and disease stage 
were included as fixed factors, while age and ICV were modeled as continuous covariates. To 
ensure that the models detect relationships related to apathy, we included depression as a 
covariate due to their potentially significant relationship. The dependent variable in each model 
was apathy, while the independent variables consisted of the SBM components or segmented 
subcortical volumes. Due to the abnormal distribution of the residuals and variables in the 
regression model, we decided to normalize apathy, depression, age, sex, ICV, and the subcortical 
volumes through a square-root transformation. Outliers greater than 3 standard deviations did not 
significantly affect the results. 
Figure 7 
FBIRN Component #16 
Note. These values represent positive z values. This component shows gray matter variation 
in the caudate, putamen, and thalamus. 
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 For prHD, we constructed four regression models for the SBM analysis and subcortical 
volumes respectively. The first one included all the components and subcortical volumes, in their 
respective models, as independent variables (inclusive model). The rest of the models analyzed 
the relationship of apathy with each component or subcortical volume without taking into 
account the other measures (isolation models). Additionally, we also constructed regression 
models without controls for the sake of consistency with the schizophrenia data. 
 For schizophrenia, we initially constructed five regression models for the SBM analysis 
and subcortical volumes, respectively. The first one included all of the components (inclusive 
model) and subcortical volumes, in their respective models, as independent variables. The rest of 
the models analyzed the relationship of apathy with each component or subcortical volume 
without taking into account the other measures (isolation models). 
Results 
Prodromal Huntington’s Disease 
 Apathy was significantly related to caudate gray matter volume in both the SBM (β = -
0.09; t(814) = 2.31; p < 0.05) and BRAINSTools isolation models (β = -0.12; t(814) = - 3.43; p < 
0.05). These significant relationships with the caudate were also found in the inclusive model. 
There seems to be a negative relationship between apathy and gray matter in the caudate, so 
apathy increases as gray matter volume in the caudate decreases. This pattern holds for the 
putamen in the BRAINSTools model (β = - 0.12; t(814) = - 3.06; p < 0.05), but only for the 
isolation model. No such relationship was found with the resulting SBM component most 
representative of the putamen (β = -0.02; t(814) = -0.66; p > 0.05). There was no significant 
relationship between the thalamus in the BRAINSTools model (β = -0.02; t(814) = - 0.789; p > 
0.05) or SBM model (β = - 0.02; t(814) = - 0.62; p > 0.05). Age displayed a significant negative 
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relationship with apathy (β = -0.08; t(814) = - 2.5; p < 0.05). All of these results were replicated 
in the models that excluded controls (n = 649). As expected, apathy was significantly related to 
depression in all models. See table 3 and 4 contain for further details. 
 
 
Table 3 
prHD Apathy and caudate (SBM model) 
  
Independent 
Variable 
β Estimate SE t Value t Value (No 
controls) 
Low/Medium/High 0.004/-0.03/0.02 0.09/0.08/0.08 0.05/-0.33/0.26 NA/-0.36/0.24 
ICV -0.02 0.04 -0.51 -0.01 
Sex 0.08 0.06 1.4 0.92 
Age -0.08 0.03 -2.5** -2.6** 
Depression 0.66 0.03 22.8*** 20.68*** 
Component #3 -0.09 0.03 -2.76** -2.71** 
Note. * p < 0.05 
         ** p < 0.01 
         *** p < 0.001 
Table 4 
prHD Apathy and caudate (BRAINSTools model) 
  
Independent 
Variable 
β Estimate SE t Value t Value (No 
controls) 
Low/Medium/High -.01/-0.07/-0.05 0.08/0.08/0.09 -0.06/-0.85/-
0.59 
NA/-0.85/-0.64 
Sex 0.08 0.06 1.473 0.87 
Age 201/226/222 N/A -2.48** -2.62** 
Depression 0.66 0.03 22.96*** 20.9*** 
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Schizophrenia 
 Apathy was significantly related to the putamen gray matter volume in the SBM model (β 
= -0.69; t(170) = -2.48; p < 0.05) (Table 4), while the FreeSurfer model didn’t show any 
significant relationships. This result was replicated when the dependent variable was a 
combination of the SANS avolition and apathy scores (β = -0.43; t(170) = - 2.31; p < 0.05). 
However, this result was only true in the models that included all components/volumes. The 
isolation model that only included the putamen component did not find a significant relationship 
with apathy (β = -0.43; t(173) = - 1.71; p > 0.05). Post-hoc models including only components 
that had some overlap or relation to the putamen region (components 1 and 16) yielded a 
significant result (β = -0.62; t(171) = -2.24; p < .05). However, any combination of the three 
components yielded a significant relationship between component #15 and apathy. Volumetric 
data and components representative of the thalamus and caudate were not found to be 
significantly related to apathy. As expected, apathy was significantly related to depression in all 
models.  
Table 4 
SZ Apathy and putamen (SBM model) 
 
Independent Variable β Estimate SE t Value 
ICV -0.26 0.31 -0.82 
Sex 1.05 0.64 1.65 
Caudate volume -0.12 0.03 -3.43*** -3.63*** 
Putamen volume -0.12 0.04 -3.01** -3.8*** 
Note. * p < 0.05 
         ** p < 0.01 
         *** p < 0.001 
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Age 0.02 0.03 0.92 
Depression 0.41 0.18 2.24* 
Component #1 0.46 0.27 1.67 
Component #11 -0.37 0.31 -1.2 
Component #15 -0.69 0.28 -2.48* 
Component #16 -0.23 0.28 -0.81 
Note. * p < 0.05 
         ** p < 0.01 
         *** p < 0.001 
 
Discussion 
 In HD, the results indicate a significant negative relationship between apathy and gray 
matter volume in the caudate and the putamen in the volumetric model, while the SBM model 
found a significant negative relationship only with the caudate. In schizophrenia, the results 
indicate a significant negative relationship between apathy and gray matter volume in the 
caudate in the SBM model, while the volumetric model didn’t find any significant relationship 
with apathy. On top of this distinction, the SBM regression model that evaluated apathy as a 
function of the putamen component in the absence of the other components did not yield a 
significant result.  
 In the schizophrenia analysis, regression models differed on results based on the number 
of components included in the model. When all of the components were included in the model, 
there was a significant relationship between the putamen component and apathy. In contrast, 
when analyzing the relationship between apathy and the putamen component in isolation, no 
significant relationship is detected. This suggests that a significant relationship is only detectable 
when taking into account the error variance of the other components. One possibility is that there 
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are other components that also include the putamen, which introduce more variance into the 
model. To examine this a bit closer, we constructed models that examined the relationship of 
apathy three of the four components at a time with the putamen component being the only 
constant. All models were significant in this situation. This means that the putamen component 
does not seem to explain apathy in isolation and something from the other components is 
important for the putamen component’s relationship with apathy. Prior literature supports the 
role of the putamen in apathy within the context of schizophrenia (Knustson et al., 2000; Koch et 
al., 2010), so we do not think this finding is insignificant. That being said, the state of the current 
analysis makes a bit complicated to clearly interpret these results, but it seems to us that the 
putamen component is related to apathy and is, therefore, worth discussing further. 
While there does seem to be a similar physiological relationship with apathy in both 
disorder in the case of the putamen, HD models also implicated the caudate as region related to 
apathy. One reason for this discrepancy could be that HD and schizophrenia both induce apathy 
at different points in the process of goal-directed behavior, so these disorders could be affecting 
different structures that are associated with different features of apathy. Another reason could be 
due to the difference in how apathy is measured on the respective scales for each disorder (FrSBe 
vs. SANS).  
Multidimensionality of Apathy 
 In this study, like most others, we used scales that define apathy along one dimension. 
The SANS and FrSBe have an apathy subscale, but both measure it as a one-dimensional 
concept. The main problem with using these scales is that it results in an attempt to collapse 
several dimensions, which potentially have different physiological profiles and forms of 
manifestation, into one. There is evidence to suggest that the three general dimensions of apathy, 
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cognitive, emotional (affective), and behavioral (auto-activation), manifest in unique structures 
within the fronto-basal ganglia circuit (Bortolon et al., 2014). In Levy & Dubois (2006), the 
authors describe the three aforementioned dimensions and review some evidence indicating that 
each dimension differentially affects unique frontal and striatal regions. They found that 
cognitive apathy, which is related to executive dysfunctions, is related to lesions in the lateral 
PFC and the head of the caudate nucleus. In the emotional domain of apathy, they found that it is 
related to the orbital and medial PFC projections to the ventral striatum. For the auto-activation 
domain, they found that it is related to the internal portion of the globus pallidus (GPi) and 
caudate. A more recent study found some similar results, showing that different neural circuits 
are involved with different profiles of apathy (Quaranta et al., 2012). This suggests that apathy 
isn’t a one-dimensional symptom and it requires a multidimensional approach to fully 
encompass. 
There are various problems with analyzing apathy with this paradigm. First, the number 
of items representing apathy varies. Depending on the items, this causes one scale to measure 
along a certain dimension more than the other, so the definition of the construct that is apathy is 
shifted in each scale. The global avolition/apathy item on the SANS can potentially mitigate the 
effect, but that also introduces a purely subjective rating of a symptom that requires caretakers to 
simultaneously consider the full range of their patient’s behavior, which doesn’t make for a good 
measurement in isolation. Second, the nature of the items is different. There may be items on one 
scale that try to measure some aspect of apathy (e.g., persistence) but no comparable items on the 
other scale. This can lead to one scale defining apathy more along a certain dimension than the 
others compared to the other scale, which leads to a difference in definition. Third, the items are 
worded differently. At first glance, this may seem a bit nitpicky to point out but years of 
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psychological research has shown that even the smallest of changes in the framing of questions 
or statements can cause people to perceive it differently. Following the same line of logic, the 
lack of standardization when it comes to the wording can create a serious issue when it comes to 
rating because the person rating could be rating apathy differently. This is, in no small part, due 
to the lack of consensus around a standard definition and diagnosis of apathy. All this being said, 
a lot of these scales may, in part, measure the other dimensions of apathy in some of its other 
items. For example, the SANS has an apathy subscale, which mainly focuses on behavioral 
apathy, but some of its other subscales, such as asociality and affective blunting, obviously delve 
into the territory of other domains. Even though these scales provide limited measurements of 
multiple dimensions of apathy, they also tend to measure more of one dimension than another. 
The lack of standardization prevents these scales to truly achieve construct and biological 
validity. When it comes to psychometric scales and accurate measurements, it is imperative that 
the construct is clear and items are standardized to ensure construct validity. 
Schizophrenia and Huntington’s Disease Neuroanatomy 
 Our results indicate that different areas in HD and schizophrenia were associated with 
apathy. For prodromal HD, we found that apathy was significantly related to a decrease in 
caudate and putamen gray matter volume. It is important to note that both the SBM and 
volumetric models indicated a significant relationship with the caudate, but only the volumetric 
model identified a relationship with the putamen. For schizophrenia, we found that apathy 
significantly related to a decrease in putamen gray matter volume. In this case, only the SBM 
model identified this relationship. These results are interesting in two ways: 1) different striatal 
structures were identified in each disorder and 2) the SBM and volumetric models produced 
different results. 
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 The fact that certain structures were identified in each disorder is something that 
necessitates further discussion and study. Within the context of this study, this could be due to 
several reasons. The first reason is that apathy could manifest itself differently in each disorder, 
which is to say that it manifests through different structures and pathways. For HD, the main 
striatal region we found to be significantly related to apathy, with the SBM model, is the caudate 
nucleus. In this component, we also found other covarying areas, such as the putamen and medial 
frontal region, that also showed a decrease in gray matter volume. This makes sense within the 
context of other studies that have found similar results when looking at the relationship between 
apathy and striatal gray matter in prodromal HD (Misiura et al., 2019). The neuroimaging 
literature on prodromal HD has also repeatedly found both striatal and frontal dysfunctions with 
functional and structural analyses (Paulsen 2009). Although this correlation between gray matter 
patterns does not directly imply any type of connection between the caudate and covarying areas, 
there is some anatomical evidence to suggest connectivity between these regions (Levy & 
Dubois, 2006). In addition, the caudate nucleus and medial PFC are both implicated in the 
cognitive and auto-activation domains of apathy (Levy & Dubois, 2006). Given this neurological 
profile, it seems as if the apathy items in the FrSBe are mainly related to the aforementioned 
dimensions. This makes sense to an extent when one takes a look at the items on this scale, but, 
from just reading the items, it seems as if the scale is more biased towards the auto-activation 
domain since most items ask about initiative and self-initiation. Given the coinciding prevalence 
of the striatum and frontal regions in HD and apathy, it makes sense that the type of apathy that 
manifests in this disorder is within the cognitive and auto-activation domain. For schizophrenia, 
the main striatal region we found to significantly related to apathy is the putamen. Several 
imaging studies have identified hypoactivation of the putamen in schizophrenia in reward, with 
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primary and secondary reinforcers, and reinforcements tasks (Knustson et al., 2000; Koch et al., 
2010; Waltz et al., 2009). The dorsal striatum, as a whole, is usually implicated in similar reward 
functions, although some studies have independently identified one or the other. The literature on 
this differentiation, however, is not developed enough to analyze the difference in function 
within the context of apathy. While our finding that putamen gray matter decrease is related to 
apathy is expected, it is a bit unexpected to only find that area. This could be due to the fact that 
the SANS apathy/avolition subscale only has three items with a global item. Models with the 
three items and the global rating as the independent variable yielded the same results. Having 
such a small number of items restricts out the ability to measure apathy in all of its complexity, 
opting instead for a perhaps an oversimplified model. Interestingly, the neural correlates of the 
SANS mostly coincide with the emotional and cognitive apathy, while its neuropsychological 
correlates coincide more with the cognitive domain (Morris et al., 2015; Levy & Dubois 2006). 
This is interesting because the items on the SANS apathy subscale seem to be constructed to 
measure behavioral apathy since the items mostly inquire about hygiene, persistence, and 
spontaneity. This might be another indication of the necessity to measure apathy with a 
multidimensional paradigm because it seems like the apathy items are measuring dimensions that 
do not coincide with their wording. The SBM component representative of the putamen covaries 
with the rectus and orbital medial frontal areas. The connection between the dorsal striatum and 
orbital/medial PFC is mostly associated with the emotional and cognitive domain (Bortolon et 
al., 2018; Levy & Dubois, 2006). From these results, it seems that the schizophrenic profile of 
apathy mainly consists of the emotional and cognitive domain. As shown above, it is very 
possible that these disorders, in which apathy is an important symptom, manifest different types 
of apathy. Having this type of biological validity associated without apathy measurements is 
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crucial to constructing effective pharmacological and/or therapeutic interventions. These 
different apathy profiles could also potentially serve as biomarkers for certain disorders. 
However, the lack of standardized items and multidimensional scales for apathy hinders our 
ability to properly assess apathy, which, in turn, prevents researchers, working in different 
disorders, to communicate and compare results effectively.  
 Interestingly, the observed differences between results in the SBM and segmented 
subcortical volume analyses are unique. In the prHD analysis, the volumetric model found a 
significant relationship with the putamen, while SBM did not. This could be due to the fact that 
component #3, which was designated as most representative of the caudate, also included the 
putamen. It could be that the putamen alone isn’t predictive of apathy but is significantly related 
when in conjunction with the caudate. This would explain why component #3 was significant 
since it there are covarying voxels in both regions. This is further evidenced by the fact that the 
putamen was only found to be significantly related to apathy in the isolation model. In the 
inclusive model, this effect disappeared while the effect of the caudate remained. Again, this 
seems to suggest that, since the putamen is predictive apathy when you are not accounting for the 
caudate variance, the putamen’s role might exist only in conjunction with the caudate. This 
might imply that the connectivity between the putamen and the caudate is the extent of the 
putamen’s role. In the schizophrenia analysis, the SBM model found that component #15, which 
was designated as most representative of the putamen, was significantly related to apathy, while 
the volumetric models found no such relationship. This could be due to the different nature of the 
analyses. SBM is a multivariate approach that considers the relationship between the voxels, 
which can then be compared across groups, while the segmented subcortical volumes analysis 
was a univariate approach. SBM has been previously found to be able to detect the same regions 
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as other univariate analyses and other regions of interest that the univariate analysis could not 
(Xu et al., 2008). It is possible that this could just be representative of SBM being a more 
powerful analysis.  
Limitations 
 This study had several limitations that need to be considered before interpreting the 
results. Broadly speaking, the type of analysis used was correlational in nature. SBM analysis 
examines the correlation between voxels to reveal underlying spatial patterns that are 
independent of one another. Although this method is a powerful multivariate way to evaluate the 
relationship between voxels and compare between groups, it relies on correlations between 
voxels. While it is tempting to assume that this correlation between voxels implies anatomical 
and functional connectivity, this may not be the case. As a result, the results of the regression 
analysis cannot be used to draw specific causal links on its own merit. Another problem is that 
we picked the SBM components manually and, therefore, introduced a subjective factor that is 
vulnerable to error. An automatic classification system, perhaps via machine learning, would 
greatly increase the validity of studies using the SBM approach.  
 With respect to PREDICT-HD and FBIRN, one of the differences is that our sample for 
PREDICT-HD included controls, while the sample for FBIRN did not. We do not think this had 
much impact on the results since we were studying apathy in the context of the disorders. 
However, we took measures to mitigate whatever effect this could have by running a parallel 
analysis on the prHD sample without controls. The results turned out to be the same, which 
supports the idea that this discrepancy did not have a significant impact on the results. Another 
difference was the algorithm used to segment the subcortical volumes; BRAINSTools was used 
for PREDICT-HD, while Freesurfer was used for FBIRN. This can introduce unneeded error 
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variance between the models, which could skew the results. Although we don’t have any reason 
to believe this difference had a significant impact, the models should be treated as similarly as 
possible for the sake of valid comparison. There was also the issue of using different scales that 
are disease specific and attempting to compare one of their subscales. Even though this subject 
has already been thoroughly discussed above, it does present an issue because the relationships 
found in this study could have been based on the scales measuring different constructs or 
different dimensions of the same construct. The scale scores themselves pose an issue since they 
represent a simplification of a multidimensional symptom. 
Conclusion  
 Our results suggest that there is different apathy related striatal gray matter patterns in 
HD and schizophrenia. Even though both disorders exhibited a decrease in gray matter volume, 
each disorder had a different structure that was significantly related to apathy. In HD, we found 
that caudate and putamen atrophy was significantly related to apathy, while, in schizophrenia, we 
found that putamen atrophy was significantly related to apathy. By using the multivariate 
analysis SBM, we were also able to identify other covarying areas within the significant 
components. For HD, we found that the caudate covaried with the putamen and medial frontal 
PFC. For schizophrenia, we found that the putamen covaried with the recuts and orbital medial 
frontal regions. Using previous studies indicating the multidimensionality of apathy, we 
discussed how the structures significantly related to apathy potentially mapped on to previously 
identified fronto-striatal circuits unique to certain dimensions. The fact that the results from both 
disorders mapped onto the different neural correlates of different dimensions could suggest that 
HD and schizophrenia manifest different profiles of apathy with unique neural underpinnings. It 
could also reflect the fact that scales used to measure apathy in these disorders defines it as a 
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one-dimensional symptom when the literature indicates that apathy is multifaceted. In other 
words, it could be that the scales measure one dimension more than the rest and this leads to the 
bias in our results.  
Future studies attempting to compare apathy across several disorders should consider 
using scales that account for the different dimensions of apathy. To our knowledge, there are 
only two scales that take a multidimensional approach to measuring apathy: AES (Faerden et al., 
2008) and LARS (Yazbek et al., 2014). By using these scales to compare across a population of 
both disorders, we could begin to have an effective and meaningful conversation about a 
standard definition for apathy. It will also allow researchers to start verifying the physiology of 
apathy, especially since the literature has contradictory results possible due to the lack of scales 
that consider the multidimensionality of apathy (Bortolon et al., 2018). Another reason the 
apathy literature is in such an erratic state is that there is no base that unifies or enables the 
comparison of the current findings. If there is no consensus around a definition of apathy, then 
there’s no way to uncover its true physiology since the scales we depend on will measure 
different aspects of the construct. Future studies should also focus more on the actual 
connections between regions, which can be achieved through analyses like DTI. It is essential to 
verify the impact of the previously implicated dopaminergic fronto-striatal projections directly as 
opposed to inferring it from similar symptomology due to independent lesions of two different 
regions. 
To construct proper pharmacological and therapeutic interventions for apathy and these 
disorders as a whole, it is imperative that the psychiatric community works towards a consensus 
on the definition of apathy so that future scales can be standardized. It is also important that the 
community works towards scales that measure apathy with a multidimensional paradigm. This 
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will enable the community to create and verify biologically relevant apathy measurements that 
will enable the effective crosstalk between symptomological data across disorders. This will, 
undoubtedly, lead a much better understanding of apathy and its parent disorders, which could 
result in novel and effective treatment methods. 
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